Le Lézard
Classified in: Health, Covid-19 virus

Sales of Shark Tank Winning Immune Support Product EZC Pak Soar Amid COVID-19 Outbreak


LOS ANGELES, Nov. 25, 2020 /PRNewswire-PRWeb/ -- E-Z-C Pak, the first physician formulated immune support pack composed of Echinacea, Zinc, and Vitamin C designed to reduce antibiotic overuse in cold and flu has surged in demand amid the COVID-19 outbreak. Company spokesperson Julianne Jahn reported that brand sales are up over 850% online and over 300% overall from the previous fiscal year. The company's Vitamin D product EZC Pak+D, launched last year, has become a top online seller, bolstered by research showing COVID-19 positive patients are four times less likely to require admission to intensive care units (ICUs) if they have normal levels of Vitamin D.

EZC Pak has won six awards over the past three years and was featured in a deal-winning over-the-top episode in Season 11 of structured reality television series Shark Tank.

"The COVID-19 pandemic has been one of the saddest periods of American history. The outbreak has exposed fundamental structural problems with the design of the US healthcare system. The inadequacies of our healthcare system across the management of infectious diseases and public health outbreaks, to psychiatric care, to the medical education system, to the coordination between public health agencies, to the dissemination of accurate health information to the American public has been on full display," said CEO Sarath Malepati, MD.

"Antibiotics still don't treat viruses. Yet antibiotic abuse has been extremely high this year. Superbugs are going to continue to be a problem both in healthcare facilities and the community for as long as bad medicine and bad healthcare continues to be our chosen path. These are complex problems that require humility, collaboration, and a long term outlook to solve. We have yet to reach that point," Malepati said.

Dr. Malepati stated that funds from EZC Pak's most successful year of sales to date will be allocated to ongoing support for antibiotic stewardship initiatives in community clinics in medically under-resourced areas of the US, international expansion, and building out the company's clinical research program. "We have an uphill battle against superbugs, but we're not done fighting," he said.

About EZC Pak:

EZC Pak is the first physician formulated Immune Support Pack composed of certified organic Echinacea, Zinc, and Vitamin C designed to reduce the problem of antibiotic overuse in colds and flu. For more information on where to buy EZC Pak in your neighborhood, please visit the store locator at ezcpak.com.

Media Contact

Julianne Jahn, PPC Group, +1 (310) 991-3015, [email protected]

Facebook

 

SOURCE EZC Pak


These press releases may also interest you

at 06:45
The "Global Pediatric Interventional Cardiology Market, Size, Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has been added to  ResearchAndMarkets.com's offering. The Global Pediatric...

at 06:30
The "Sample Preparation Market by Product (Workstation, Instrument {Pipette, Washer, Centrifuge, Grinder}, Consumable {Kits, Filters, Plates}) Technique (Solid Phase Extraction, Purification) Application (Drug Discovery, Diagnostic) - Global Forecast...

at 06:15
The "Global Immune Health Supplements Market - Outlook & Forecast 2023-2028" report has been added to  ResearchAndMarkets.com's offering. The global immune health supplements market was valued at $20.80 billion in 2022 and is expected to reach...

at 06:08
ConTemporary Locums, a physician-focused medical staffing company, is ushering in a new era with a bold rebrand: Era Locums. This brand evolution marks a commitment to continued innovation and a deeper connection with the company's physician and...

at 06:05
AIS Healthcare, a leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to recognize March 25-31 as National Physicians Week. This week and throughout the year, we celebrate the dedication of physicians who selflessly...

at 06:00
The "Liquid Biopsy Markets by Cancer, Usage, Biomarker, Place, & Product With Price and Volume Outlook. Including Executive and Consultant Guides and Customized Forecasting and Analysis 2023-2027" report has been added to  ResearchAndMarkets.com's...



News published on and distributed by: